Skip to main content
. 2021 Jun 28;18(13):6936. doi: 10.3390/ijerph18136936

Table 5.

The adjusted odds ratios of gestational diabetes mellitus (GDM-1, -2) for declared diabetes in the parents.

Risk Factors/
Diabetes in the Parents
Cases/
Controls
OR (95% CI); p AOR-A (95% CI); p * AOR-B (95% CI); p *
GDM-1 risk
-in the father 32/74 3.90 (2.39–6.37); <0.001 3.71 (2.25–6.12); <0.001 3.68 (2.23–6.07); <0.001
-in the mother 14/52 2.43 (1.27–4.63); 0.007 2.13 (1.1–4.14); 0.026 2.13 (1.1–4.14); 0.026
-in the mother or father 42/112 3.38 (2.18–5.26); <0.001 3.21 (2.05–5.04); <0.001 3.20 (2.03–5.02); <0.001
-in both parents simultaneously 4/14 2.58 (0.82–8.07); 0.104 1.88 (0.58–6.14); 0.293 1.88 (0.58–6.13); 0.294
Ref ** 62/559 1 1 1
GDM-2 risk
-in the father 4/74 2.75 (0.85–8.85); 0.09 2.93 (0.87–9.88); 0.083 3.16 (0.78–12.81); 0.108
-in the mother 4/52 3.91 (1.2–12.71); 0.023 3.36 (0.97–11.62); 0.056 4.73 (1.26–17.77); 0.021
-in the mother or father 8/112 3.63 (1.43–9.23); 0.007 3.76 (1.42–9.99); 0.008 4.77 (1.59–14.25); 0.005
-in both parents simultaneously 0/14 - - -
Ref ** 11/559 1 1 1
GDM (all cases) risk
-in the father 36/74 3.73 (2.34–5.94); <0.001 3.51 (2.18–5.66); <0.001 3.49 (2.15–5.67); <0.001
-in the mother 18/52 2.65 (1.47–4.78); 0.001 2.24 (1.22–4.12); 0.009 2.32 (1.26–4.28); 0.007
-in the mother or father 50/112 3.42 (2.26–5.17); <0.001 3.2 (2.09–4.89); <0.001 3.23 (2.1–4.97); <0.001
-in both parents simultaneously 4/14 2.19 (0.7–6.82); 0.177 1.49 (0.46–4.82); 0.509 1.51 (0.46–4.91); 0.494
Ref ** 73/559 1 1 1

* AOR: adjusted odds ratios (95% confidence intervals) calculated in multiple logistic regression after adjusted for multiparity, pre-pregnancy BMI, age, gestational weight gain (GWG) out of the range as well as smoking in the first trimester (AOR-a), plus prior gestational diabetes mellitus (AOR-b) (p-value < 0.05 was assumed to be significant). ** Reference category: ‘Absence of diabetes in the family’. Cases: GDM-1, i.e., diabetes treated with diet (n = 125); GDM-2, i.e., diabetes treated with insulin (n = 21). Controls: non-diabetic women (n = 766).